Microbiotica is a biotech company focused on the microbiome science. It identifies gut bacteria linked to patient phenotype for the discovery of microbiome-based medicines and biomarkers of drug response. The company is engaged in inflammatory bowel disease (IBD), immune-oncology, and Clostridium difficile programs.